CLOVER HEALTH INVESTMENTS, CORP. (CLOV) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$4.79
+4.6% on the day
+79.4% over 12 months
52-week range $1.70 – $5.41
Share price and insider trades
CLOV closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$8.2M
Insiders buying0
Insiders selling8
CLOVER HEALTH INVESTMENTS, CORP. insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $8.2M of CLOV stock on the open market.
Get emailed when insiders cluster-buy stocks like CLOV
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CLOV insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $1.4M | 3 |
| Q3 2026 | — | 0 | $4.6M | 18 |
| Q2 2026 | — | 0 | $1.6M | 8 |
| Q1 2026 | — | 0 | $408K | 4 |
| Q4 2025 | — | 0 | $171K | 4 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.5×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 CLOVER HEALTH INVESTMENTS, CORP. /DE insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $8.2M. 33 of 37 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 7SEC | Jamie L. ReynosoCEO | Sell Plan | 2,0062,792,690 held (−0%) | $4.63 | $9K | +3.5% | — |
| Oct 5SEC | Jamie L. ReynosoCEO | Sell Plan | 8,7502,794,696 held (−0%) | $4.42 | $39K | +8.4% | — |
| Oct 2SEC | Andrew ToyCEO | Sell Plan | 318,8069,140,510 held (−3%) | $4.19 | $1.3M | +14.3% | — |
| Sep 18SEC | Jamie L. ReynosoCEO | Sell Plan | 1,9212,803,446 held (−0%) | $4.56 | $9K | +5.0% | — |
| Sep 17SEC | Joseph Frank OldakowskiVp Of Finance And Controller | Sell Plan | 3,170275,897 held (−1%) | $4.64 | $15K | +3.2% | — |
| Sep 16SEC | Conrad WaiCEO | Sell Plan | 300,0001,170,056 held (−20%) | $4.72 | $1.4M | +1.5% | — |
| Sep 15SEC | Jamie L. ReynosoCEO | Sell Plan | 9,2732,805,367 held (−0%) | $4.78 | $44K | +0.2% | — |
| Sep 15SEC | Karen SoaresGeneral Counsel | Sell Plan | 6,8461,607,371 held (−0%) | $4.78 | $33K | +0.2% | — |
| Sep 14SEC | Joseph Frank OldakowskiVp Of Finance And Controller | Sell | 20,000279,067 held (−7%) | $5.16 | $103K | -7.2% | — |
| Aug 17SEC | Joseph Clay ThorntonCFO | Sell Plan | 17,7751,249,526 held (−1%) | $4.39 | $78K | +9.1% | — |
| Aug 10SEC | Andrew ToyCEO | Sell Plan | 87,7989,459,316 held (−1%) | $4.65 | $408K | +3.0% | — |
| Jul 20SEC | Karen SoaresGeneral Counsel | Sell Plan | 51,7001,505,522 held (−3%) | $4.51 | $233K | +6.2% | — |
| Jul 17SEC | Jamie L. ReynosoCEO | Sell Plan | 4,8392,814,640 held (−0%) | $4.53 | $22K | +5.7% | — |
| Jul 16SEC | Andrew ToyCEO | Sell Plan | 62,7119,547,114 held (−1%) | $4.67 | $293K | +2.6% | — |
| Jul 16SEC | Conrad WaiCEO | Sell Plan | 24,2151,145,699 held (−2%) | $4.67 | $113K | +2.6% | — |
| Jul 16SEC | Jamie L. ReynosoCEO | Sell Plan | 13,1192,819,479 held (−0%) | $4.67 | $61K | +2.6% | — |
| Jul 16SEC | Karen SoaresGeneral Counsel | Sell Plan | 10,5191,557,222 held (−1%) | $4.67 | $49K | +2.6% | — |
| Jul 16SEC | Joseph Clay ThorntonCFO | Sell Plan | 4,6301,212,954 held (−0%) | $4.67 | $22K | +2.6% | — |
| Jul 9SEC | Jamie L. ReynosoCEO | Sell Plan | 2,3842,832,598 held (−0%) | $4.68 | $11K | +2.4% | — |
| Jul 6SEC | Jamie L. ReynosoCEO | Sell Plan | 6,2292,834,982 held (−0%) | $5.26 | $33K | -8.9% | — |
| Jul 1SEC | Andrew ToyCEO | Sell Plan | 313,4769,609,825 held (−3%) | $5.32 | $1.7M | -10.0% | — |
| Jun 18SEC | Jamie L. ReynosoCEO | Sell Plan | 2,3602,841,211 held (−0%) | $4.78 | $11K | +0.2% | — |
| Jun 17SEC | Joseph Frank OldakowskiVp Of Finance And Controller | Sell Plan | 12,102299,067 held (−4%) | $4.86 | $59K | -1.4% | — |
| Jun 16SEC | Jamie L. ReynosoCEO | Sell Plan | 6,3502,843,571 held (−0%) | $4.61 | $29K | +3.9% | — |
| Jun 16SEC | Karen SoaresGeneral Counsel | Sell Plan | 4,6811,567,741 held (−0%) | $4.61 | $22K | +3.9% | — |
| Jun 11SEC | Jamie L. ReynosoCEO | Sell Plan | 7,2892,849,921 held (−0%) | $4.91 | $36K | -2.4% | — |
| May 28SEC | Conrad WaiCEO | Sell Plan | 220,4261,390,056 held (−14%) | $3.99 | $879K | +20.1% | — |
| May 19SEC | Carladenise Armbrister EdwardsDirector | Sell | 67,160285,432 held (−19%) | $3.42 | $230K | +40.1% | — |
| May 13SEC | Brady Patrick PriestCEO | Sell | 98,0392,040,222 held (−5%) | $3.52 | $345K | +36.1% | — |
| Mar 18SEC | Jamie L. ReynosoCEO | Sell Plan | 5,8332,716,735 held (−0%) | $1.91 | $11K | +150.8% | — |
| Mar 5SEC | Brady Patrick PriestCEO | Sell | 175,0001,998,584 held (−8%) | $2.17 | $380K | +120.7% | — |
| Jan 20SEC | Jamie L. ReynosoCEO | Sell Plan | 4,5972,737,700 held (−0%) | $2.58 | $12K | +85.7% | — |
| Jan 7SEC | Jamie L. ReynosoCEO | Sell Plan | 2,1022,757,029 held (−0%) | $2.53 | $5K | +89.3% | — |
| Dec 18SEC | Jamie L. ReynosoCEO | Sell Plan | 4,9132,767,240 held (−0%) | $2.61 | $13K | +83.5% | — |
| Nov 5SEC | Jamie L. ReynosoCEO | Sell Plan | 30,3852,793,411 held (−1%) | $3.58 | $109K | +33.8% | — |
| Oct 21SEC | Jamie L. ReynosoCEO | Sell Plan | 16,5142,955,226 held (−1%) | $2.69 | $44K | +78.1% | — |
| Oct 7SEC | Jamie L. ReynosoCEO | Sell Plan | 2,0123,043,172 held (−0%) | $2.65 | $5K | +80.8% | — |
Insiders at CLOVER HEALTH INVESTMENTS, CORP. /DE
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Andrew ToyCEO | — | $3.7M | Oct 2, 2026 | — |
| Conrad WaiCEO | — | $2.4M | Sep 16, 2026 | — |
| Brady Patrick PriestCEO | — | $725K | May 13, 2026 | — |
| Jamie L. ReynosoCEO | — | $504K | Oct 7, 2026 | — |
| Karen SoaresGeneral Counsel | — | $337K | Sep 15, 2026 | — |
| Carladenise Armbrister EdwardsDirector | — | $230K | May 19, 2026 | — |
| Joseph Frank OldakowskiVp Of Finance And Controller | — | $177K | Sep 17, 2026 | — |
| Joseph Clay ThorntonCFO | — | $100K | Aug 17, 2026 | — |
CLOV stock: common questions
Are CLOVER HEALTH INVESTMENTS, CORP. /DE insiders buying CLOV stock?
In the past 12 months, 0 insiders reported open-market purchases of CLOV worth $0.
Are CLOVER HEALTH INVESTMENTS, CORP. /DE insiders selling CLOV stock?
8 insiders reported sales worth $8.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CLOV's 52-week range?
Over the past year CLOV has traded between $1.70 and $5.41. It last closed at $4.79 on Oct 9, 2026.